肥胖影响心肌梗塞后的神经血管通过通过TRPC5-NFATc3信号通路下调AQP1表达来影响心肌梗塞后的神经血管
Mengru Gao1,2,3, Jing Han1, Yifei Zhu1,3
1Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Comprehensive Physiology
|September 17, 2025
概括
肥胖会通过降低TRPC5.5来影响心脏病发作恢复. 里卢激活TRPC5,改善肌心梗塞 (MI) 的肥胖小鼠的血管形成和心脏功能.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 肥胖问题研究研究
背景情况:
- 肥胖与心肌梗塞 (MI) 后恢复不良有关,原因是血管生成受损.
- 肥胖症中血管新生受损的分子基础尚不清楚.
- 暂时受体潜在阴离子通道子家族C成员5 (TRPC5) 影响血管生成,但其在与肥胖相关的MI中的作用尚不清楚.
研究的目的:
- 研究TRPC5在与肥胖有关的心肌梗塞 (MI) 中的作用.
- 探索TRPC5激活使用riluzole在MI后肥胖个体中的治疗潜力.
主要方法:
- 研究了TRPC5表达在肥胖小鼠的心脏后MI.
- 评估了瑞卢对来自饮食诱导肥胖 (DIO) 小鼠的冠状动脉内皮细胞的影响.
- 在肥胖小鼠中评估了MI后的新血管化,心脏病发作大小和心脏功能.
- 使用基因沉默研究了TRPC5-NFATc3-AQP1通路.
主要成果:
- 在心脏病发作后,肥胖小鼠的心脏中TRPC5的表达下调,损害了血管功能.
- 在肥胖小鼠中,瑞卢治疗恢复了内皮细胞功能,增强了后心脏病发作后的新血管化,减少了心脏病发作的大小,并改善了心脏功能.
- TRPC5介导的血管生成依赖于通过NFATc3调节的水蛋白-1 (AQP1),而AQP1则起到关键的下游效应因子的作用.
结论:
- 在肥胖症中,TRPC5-NFATc3-AQP1通路对于MI后血管生成至关重要.
- 瑞卢作为治疗剂,有望改善心脏病发育和心脏病结果,在心脏病发作后肥胖个体.
相关概念视频
01:26Coronary Artery Disease II: Pathophysiology
375
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
375
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
01:29Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734
01:26Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
01:29Hypertension II: Pathophysiology
803
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
803